Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsThe authors critically discuss current knowledge regarding predictive biomarkers for checkpoint inhibitor-based immunotherapy, highlight the missing/unclear links and emphasise the importance of characterising each neoplasm and its microenvironment in order to better guide the course of treatment.
[British Journal of Cancer]
6445218 U8IG5XYV items 1 apa 0 default asc 1 163311 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-51653859a044ce6cd2385c0fc8a874c9%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22U8IG5XYV%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pilard%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPilard%2C%20C.%2C%20Ancion%2C%20M.%2C%20Delvenne%2C%20P.%2C%20Jerusalem%2C%20G.%2C%20Hubert%2C%20P.%2C%20%26amp%3B%20Herfs%2C%20M.%20%282021%29.%20Cancer%20immunotherapy%3A%20it%26%23x2019%3Bs%20time%20to%20better%20predict%20patients%26%23x2019%3B%20response.%20%3Ci%3EBritish%20Journal%20of%20Cancer%3C%5C%2Fi%3E%2C%201%26%23x2013%3B12.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41416-021-01413-x%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41416-021-01413-x%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DU8IG5XYV%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cancer%20immunotherapy%3A%20it%5Cu2019s%20time%20to%20better%20predict%20patients%5Cu2019%20response%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Pilard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ancion%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Delvenne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Jerusalem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pascale%22%2C%22lastName%22%3A%22Hubert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Herfs%22%7D%5D%2C%22abstractNote%22%3A%22In%20less%20than%20a%20decade%2C%20half%20a%20dozen%20immune%20checkpoint%20inhibitors%20have%20been%20approved%20and%20are%20currently%20revolutionising%20the%20treatment%20of%20many%20cancer%20%28sub%29types.%20With%20the%20clinical%20evaluation%20of%20novel%20delivery%20approaches%20%28e.g.%20oncolytic%20viruses%2C%20cancer%20vaccines%2C%20natural%20killer%20cell-mediated%20cytotoxicity%29%20and%20combination%20therapies%20%28e.g.%20chemo%5C%2Fradio-immunotherapy%29%20as%20well%20as%20the%20emergence%20of%20novel%20promising%20targets%20%28e.g.%20TIGIT%2C%20LAG-3%2C%20TIM-3%29%2C%20the%20%5Cu2018immunotherapy%20tsunami%5Cu2019%20is%20not%20about%20to%20end%20anytime%20soon.%20However%2C%20this%20enthusiasm%20in%20the%20field%20is%20somewhat%20tempered%20by%20both%20the%20relatively%20low%20percentage%20%28%3C15%25%29%20of%20patients%20who%20display%20an%20effective%20anti-cancer%20immune%20response%20and%20the%20inability%20to%20accurately%20identify%20them.%20Recently%2C%20several%20existing%20or%20acquired%20features%5C%2Fparameters%20have%20been%20shown%20to%20impact%20the%20efficacy%20of%20immune%20checkpoint%20inhibitors.%20In%20the%20present%20review%2C%20we%20critically%20discuss%20current%20knowledge%20regarding%20predictive%20biomarkers%20for%20checkpoint%20inhibitor-based%20immunotherapy%2C%20highlight%20the%20missing%5C%2Funclear%20links%20and%20emphasise%20the%20importance%20of%20characterising%20each%20neoplasm%20and%20its%20microenvironment%20in%20order%20to%20better%20guide%20the%20course%20of%20treatment.%22%2C%22date%22%3A%222021-06-10%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41416-021-01413-x%22%2C%22ISSN%22%3A%221532-1827%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41416-021-01413-x%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-10T19%3A28%3A30Z%22%7D%7D%5D%7D
Pilard, C., Ancion, M., Delvenne, P., Jerusalem, G., Hubert, P., & Herfs, M. (2021). Cancer immunotherapy: it’s time to better predict patients’ response. British Journal of Cancer, 1–12. https://doi.org/10.1038/s41416-021-01413-x Cite
